Physician profile
Hannah E Mason
NPI 1043759319
$5,032.98
in general payments reported to CMS, 2019-2025
47 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,548 · 2022: $1,568 · 2023: $806 · 2024: $735 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,916.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,080.06 | 2021-2025 | |
| Amgen INC. | $465.62 | 2021-2024 | Prolia, Evenity, Tavneos |
| Novo Nordisk INC | $360.36 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $276.62 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $276.17 | 2021-2024 | Trintellix |
| Glaxosmithkline, LLC. | $239.49 | 2021-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $207.75 | 2021-2024 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.49 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $161.34 | 2021-2024 | Zepbound, Mounjaro, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $156.57 | 2021-2025 | |
| Harmony Biosciences LLC | $146.64 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $137.57 | 2021-2024 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $114.53 | 2021-2022 | |
| Axsome Therapeutics, INC. | $101.36 | 2023-2025 | Auvelity, Sunosi |
| Nestle Healthcare Nutrition INC. | $95.24 | 2021-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.